Evaluation of Medical Treatment for Peripheral Arterial Disease in Chinese High-Risk Patients

Abstract

PAD is prevalent in Chinese high-risk CV patients, equivalent to CHD, but these patients receive less intensive treatment than those with CHD. Programs to improve CV risk reduction in these high-risk patients are needed.